117 patients now recruited in BARDA trial with target of 120.
Now in 41 countries (up from 39 in May).
And the number 1 next to USA in this graphic was a #2 in May.
- Forums
- ASX - By Stock
- PNV
- Ann: Canaccord Genuity Growth Conference Presentation
PNV
polynovo limited
Add to My Watchlist
0.82%
!
$1.21

Ann: Canaccord Genuity Growth Conference Presentation, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.21 |
Change
-0.010(0.82%) |
Mkt cap ! $837.6M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.19 | $1.378M | 1.150M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 13475 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 20596 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 14079 | 1.205 |
28 | 31368 | 1.200 |
14 | 33973 | 1.195 |
18 | 151524 | 1.190 |
10 | 37263 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 20596 | 20 |
1.215 | 39154 | 16 |
1.220 | 105572 | 17 |
1.225 | 21541 | 9 |
1.230 | 18097 | 4 |
Last trade - 13.40pm 18/06/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online